Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis

Autor: Strieter, R M, Starko, K M, Enelow, R I, Noth, I, Valentine, V G

Publikováno v: Strieter, R M; Starko, K M; Enelow, R I; Noth, I; & Valentine, V G. (2004). Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 170(2), 133-140. UCLA: Retrieved from: http://www.escholarship.org/uc/item/6hx534td

In a recent study of IFN-gamma 1b in 330 patients with idiopathic pulmonary fibrosis (IPF), progression-free survival was unchanged; however, a trend toward lower mortality was seen in IFN-gamma 1b-treated patients compared with placebo-treated patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::a17b97ba1636fa0d7a4a28a8b8a9bd7f
http://www.escholarship.org/uc/item/6hx534td

HRCT Diagnosis of IPF and Relationship Between HRCT Characteristics and Histology and Clinical Findings in Patients in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Gamma-1b (IFN-gamma 1b)

Autor: Kevin K. Brown, Williamson Z. Bradford, W.R. Webb, Paul W. Noble, Ganesh Raghu, Karen M. Starko, J.D. Godwin, DA Lynch, David A. Schwartz

Publikováno v: Chest. 126:773S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38a218851b2af3f38a6d0c230f3e04fb
https://doi.org/10.1378/chest.126.4_meetingabstracts.773s

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.